03.05.24 | Vollzeit | Krailling | Formycon AGMarket analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon is making a major contribution
Später ansehen03.05.24 | Vollzeit | Krailling | Formycon AGMarket analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon is making a major contribution
Später ansehen03.05.24 | Vollzeit | Krailling | Formycon AGMarket analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon is making a major contribution
Später ansehen29.04.24 | Vollzeit | Krailling | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen29.04.24 | Vollzeit | Krailling | Formycon AGDrug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon is making
Später ansehen29.04.24 | Vollzeit | Krailling | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen29.04.24 | Vollzeit | Krailling | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen29.04.24 | Vollzeit | Krailling | Formycon AGDrug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon is making
Später ansehen29.04.24 | Vollzeit | Krailling | Formycon AGDrug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon is making
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Manager Field Trials in Krailling kostenlos abonnieren.